Close Menu
    Facebook X (Twitter) Instagram
    BulgariaJournal
    • Home
    • Culture
    • Energy
    • Reviews
    • Economy
    • Education
    • Tech Updates
    BulgariaJournal
    Home»Blog»A New Anaesthetic Found in Zebrafish Also Relieves Pain
    Blog

    A New Anaesthetic Found in Zebrafish Also Relieves Pain

    Alec WestBy Alec WestNovember 22, 2026No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Zebrafish larvae in a laboratory research setting.

    Researchers have discovered a new general anaesthetic that, unlike most anaesthetics, also relieves pain at doses that do not cause sedation. The compound, named nidradine, was reported in Nature Communications on 16 November 2026 by a team led by researchers at the University of California, San Francisco and the Chan Zuckerberg Biohub. They screened 12,000 compounds using a high-throughput platform that filmed the behaviour of larval zebrafish in 96-well plates, looking for chemicals that produced the same behaviour as the intravenous anaesthetics etomidate and propofol, two drugs already used in hospitals. One isoxazole chemical family matched that profile, and medicinal chemistry optimisation of it produced nidradine. Like etomidate and propofol, nidradine acts on GABAA receptors, the brain’s main inhibitory signalling system, and it proved effective in both zebrafish and mice.

    What the Evidence Shows

    Most general anaesthetics put patients to sleep without blocking pain, so pain relief during surgery usually comes from separate drugs, often opioids with their own risks. A single agent that does both could simplify anaesthesia and reduce that reliance, which is why the team screened for behaviour rather than for a single molecular target. The zebrafish platform let them test thousands of compounds quickly by watching how the tiny fish moved, rested and responded, before checking the most promising candidates in mice. The work is still at the laboratory stage: nidradine has not been tested in people, and its safety, dosing and side effects in humans are unknown. The University of California, San Francisco and the Chan Zuckerberg Biohub have applied for a patent on nidradine and related compounds. Even so, the discovery shows how behavioural screening in a small fish can find drug candidates that a purely chemical search might miss. Reporting and analysis from sources such as Nature track the same developments, and specialists following the new anaesthetic nidradine say the direction is now consistent across independent lines of evidence.

    The Wider Context

    The wider context is a research landscape in which replication and open data now decide reputations. Findings connected to the new anaesthetic nidradine are being checked by independent groups with shared datasets, and the teams involved publish their methods in full so rivals can test every step. That discipline is slower than a headline cycle, but it is why results in this area increasingly survive first contact with scrutiny.

    What Happens Next

    What happens next in the story of the new anaesthetic nidradine will be decided by follow-up work already under way: larger samples, longer observation and instruments that have not yet come online. The researchers involved are unusually united on one point, that the current results justify the next investment of time and money. Readers will not have to wait long for the first tests of that claim. You can follow related developments in our coverage of science.

    None of this will be settled by a single announcement, study or product launch. The pattern to watch is accumulation: independent confirmations, honest reporting of failures and steady improvement in the underlying numbers. Readers who follow those signals, rather than the loudest claim of the week, will understand this subject better than most of the commentary surrounding it suggests is possible.

    anaesthetics nidradine zebrafish
    Previous ArticleApple Posts $114.5 Billion Quarter but Warns of Rising Memory Costs
    Alec West

    Related Posts

    Apple Posts $114.5 Billion Quarter but Warns of Rising Memory Costs

    November 22, 2026

    Supersonic Passenger Flight Returns as Boom’s Jet Breaks the Sound Barrier

    November 20, 2026

    Microplastics Found in Human Brains at Rising Levels

    November 20, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Search
    Recent Posts

    A New Anaesthetic Found in Zebrafish Also Relieves Pain

    November 22, 2026

    Apple Posts $114.5 Billion Quarter but Warns of Rising Memory Costs

    November 22, 2026

    Supersonic Passenger Flight Returns as Boom’s Jet Breaks the Sound Barrier

    November 20, 2026

    Microplastics Found in Human Brains at Rising Levels

    November 20, 2026

    Quantum Computers Are Finally Fixing Their Own Errors

    November 19, 2026

    Ocean Dead Zones Expand as Warming Waters Lose Oxygen

    November 19, 2026
    About Us

    BulgariaJournal is your window into the culture, history, travel, and modern life of Bulgaria. We share stories that inspire, inform, and connect from

    traditions and cuisine to innovation and society offering readers fresh insights into Bulgaria and its place in the world. #BulgariaJournal

    Popular Posts

    A New Anaesthetic Found in Zebrafish Also Relieves Pain

    November 22, 2026

    Apple Posts $114.5 Billion Quarter but Warns of Rising Memory Costs

    November 22, 2026
    Contact Us

    If you have any questions or need further information, feel free to reach out to us at

    Email: tech4english@gmail. com
    Phone: +358 44 9523404

    Address: 2991 Calico Drive
    Coeur D Alene, WA 83814

     

    Copyright © 2026 | All Rights Reserved | BulgariaJournal
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    • Write for Us
    • Sitemap

    Type above and press Enter to search. Press Esc to cancel.

    WhatsApp us